Explore Westonci.ca, the top Q&A platform where your questions are answered by professionals and enthusiasts alike. Experience the ease of finding precise answers to your questions from a knowledgeable community of experts. Connect with a community of professionals ready to provide precise solutions to your questions quickly and accurately.
Sagot :
Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma.
- In this study, we assess the effectiveness of autologous cytokine-induced killer cells (CIK) transfusion combined with gemcitabine and cisplatin (GC) chemotherapy for the treatment of nasopharyngeal cancer in patients with distant metastases following radiotherapy.
- As a result, our study suggested that patients with postradiotherapy distant nasopharyngeal carcinoma metastases may benefit better from CIK cell transfusion therapy combined with GC chemotherapy.
- While the 30 patients in the GC group only received GC chemotherapy, the 30 patients in the GC+CIK group also received an adoptive autologous CIK cell transfusion.
To learn more about chemotherapy.
brainly.com/question/12147641
#SPJ4
We hope you found what you were looking for. Feel free to revisit us for more answers and updated information. Thanks for using our platform. We aim to provide accurate and up-to-date answers to all your queries. Come back soon. Keep exploring Westonci.ca for more insightful answers to your questions. We're here to help.
